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Abstract 
Introduction: Typhoid has an estimated global burden of greater than 27 million cases per annum with a clinical relapse rate of 5% to 20%.  
Despite the large relapse burden, the factors associated with relapse are largely unknown.   
Methodology: We have followed a protocol for the diagnosis and management of pediatric typhoid since 1988.  We report factors associated 
with relapse of culture-proven enteric fever in 1,650 children presenting to the Aga Khan University Medical Center,  Karachi, Pakistan, over 
a 15-year period.   
Results: In those infected with multiple drug resistant (MDR) strains, factors associated with subsequent relapse include constipation at 
presentation and presentation within 14 days of fever onset.  Diarrhoea in those children infected with drug sensitive strains had an 
association with decreased subsequent relapse, as was quinolone therapy. 
Conclusions: Multiple clinical factors at presentation are associated with subsequent typhoid fever relapse.  These factors may be postulated 
to be associated with subsequent relapse due to alterations in the reticuloendothelial system organism load.  These data will be valuable in 
developing algorithms for clinical follow-up in children infected with MDR enteric fever. 
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Introduction 
With an estimated global burden of over 27 
million cases and 200,000 deaths annually [1], 
typhoid fever causes substantial morbidity and 
mortality throughout the developing world.  
Salmonella enterica subsp. enterica serovar Typhi (S. 
Typhi) and Salmonella enterica subsp. enterica 
serovar Paratyphi (S. Paratyphi) are the causative 
agents of typhoid fever, which is known to have three 
clinical outcomes: cure, death, and a carrier state [2]. 
Those having a clinical cure may relapse in 5% to  
20% of cases within weeks to months, with 
recurrence of clinical disease that is usually milder 
than the initial illness [3].  
The emergence of multi-drug resistant (MDR) 
strains of Salmonella causing typhoid fever has been 
well documented throughout the world since the early 
1990s [4].  These strains are defined as those 
exhibiting plasmid mediated resistance to ampicillin, 
chloramphenicol, and trimethoprim-sulfamethoxazole 
and are known to cause increased morbidity and 
mortality [5].  Due to the substantial public health 
burden of typhoid fever it is important to recognize 
factors associated with an increased risk of relapse; 
however, little data is available. Such information 
would be useful in elaborating prognostic factors and 
in evolving algorithms for the follow-up management 
of children presenting with typhoid fever.   
As part of our ongoing studies on typhoid fever 
at the Aga Khan University Medical Center 
(AKUMC) in Karachi, Pakistan, we reviewed the 
frequency of relapse and factors predicting it among 
our pediatric population.  We hypothesized that the 
emergence of MDR typhoid fever would lead to a 
higher overall rate of relapse and that those patients 
infected with MDR strains who received quinolones 
or cephalosporins would be protected against relapse. 
 
Methodology 
The Aga Khan University Medical Center in 
Karachi, Pakistan (population 14 million), is a 400-
bed teaching hospital with active ambulatory care and 
pediatric services. The Department of Pediatrics has 
followed a specific protocol for the diagnosis and 
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management of suspected typhoid fever in children 
since 1988 and a database of all culture proven cases 
of typhoid fever has been maintained. In all cases, 
after a detailed clinical evaluation a complete blood 
picture and blood culture were obtained. In addition, 
a bone marrow aspirate for culture was also 
performed in cases where the child had received 
potentially active antibiotics for ≥ 72 hours prior to 
admission.  The blood or bone marrow specimens 
were inoculated into two bottles containing brain-
heart infusion broth or thioglycollate broth 
respectively. Each culture bottle was examined daily 
and colonies were subcultured onto blood agar and 
MacConkey agar after 24, 48 and 72 hours. Non-
lactose fermenting colonies from these were 
biochemically identified with API 20E strips 
(Analytab Products, Plainview, New York, USA) and 
typed for Salmonella O antigen by slide agglutination 
with specific antisera. Antibiotic susceptibility testing 
was performed by the Kirby-Bauer disc diffusion 
method [6].  For cost considerations only one blood 
culture was obtained in suspected cases and a stool 
examination and culture was restricted to cases 
presenting with diarrhoea. Other investigations such 
as urine cultures, liver function tests, serum 
electrolytes were performed as clinically indicated. 
At the onset of this protocol, cases with 
suspected typhoid fever were empirically treated with 
oral chloramphenicol or ampicillin and therapy was 
subsequently adjusted according to sensitivity results.  
In the mid 1990s, due to concerns for the increasing 
trend of multidrug resistance among typhoidal 
isolates, our protocol was modified.  Clinicians were 
then allowed, for children severely ill with toxicity or 
those who had failed to respond to first-line 
antibiotics administered prior to our evaluation, to 
hospitalize for suspicion of infection with MDR 
typhoid.  These patients then received quinolones or 
IV cephalosporins.  All patients received antibiotics 
for  ≥ 14 days depending upon the severity of illness 
and the response to the antibiotic used.  Successful 
therapy was defined as recovery from clinical illness 
with defervescence (temperature ≤ 37.5˚C for ≥ 48 
hours). Relapse was considered present with the 
recurrence of clinical disease, culture-proven 
infection with Salmonella Typhi and Paratyphi 
isolates (as described above), and with an 
antibiogram identical to the original isolates, within 
eight weeks of cessation of successful therapy of the 
initial infection. 
Data was recorded on a specially designed pro 
forma and transferred to a computer database. 
Comparative data on baseline characteristics, 
morbidity patterns, and outcome were analyzed by χ2-
test and t-test, as needed, using SPSS (Windows 
version 11.0, SPSS Inc., Chicago, Illinois). A p-value 
of 0.05 was selected as the cutoff for significance. 
The clinical protocol was approved by the 
Human Subjects Review Committee of the Aga Khan 
University. 
 
Results 
Over a 15-year period (1986-2000), a total of 
1,650 children with culture proven typhoid fever 
were seen at AKUMC with a documented follow-up 
period of  8 weeks.  Of these, 1,627 had their entire 
treatment course recorded.  Baseline characteristics 
for the cohort are provided in Table 1.  All recorded 
variables were equally distributed among relapsed 
and non-relapsed patients (data not shown) with the 
exception that those receiving partial or complete 
therapy with second-line antimicrobials were 
protected against relapse (Table 2).  We experienced 
an increase in relapse rates starting in the early 1990s 
concurrent with the emergence of MDR strains 
(Figure 1).  A total of 949 patients (57.5%) had 
infection with pan-sensitive strains of enteric fever 
and 543 patients (32.9%) with MDR strains of enteric 
fever.  The remainder were infected with strains 
displaying partial drug resistance to either one or two 
of the aforementioned antimicrobials.  Subgroup 
analysis of MDR typhoid fever cases revealed that 
the rate of relapse was higher in those initially 
presenting with rather than without constipation 
(15% versus 4.4%, p = 0.01) and in those presenting 
within 14 days of fever onset (6.4% versus 0.8%, p = 
0.01).  Patients with MDR enteric fever had a lower 
relapse rate when treated with quinolones or 
cephalosporins (Table 2), but this was not true for 
pan-sensitive or partially drug resistant strains of 
Salmonella.  Logistic regression analysis for patients 
infected with MDR strains found presentation within 
14 days of fever onset and constipation continue to be 
variables associated with relapse (p = 0.035 and p = 
0.003 respectively) whereas treatment with 
quinolones or cephalosporins during the treatment 
course continue to be associated with decreased 
relapse (p = 0.01). 
 In patients infected with pan-sensitive strains of 
enteric fever, treatment with quinolones or 
cephalosporins did not significantly alter the relapse 
rate.  In this subgroup of patients, relapse was lower 
in those presenting with rather than without diarrhoea 
(3.7% vs. 9.6%, p = 0.001).   
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Discussion 
In this report we describe our experience 
regarding enteric fever relapse spanning 15 years and 
1,650 children during the emergence of multiple-drug 
resistant strains in South Asia.  The relapse rate 
reported in our study is consistent with that described 
in the literature. Though the advent of antibiotics has 
considerably reduced morbidity and mortality 
associated with enteric fever, the relapse rate remains 
at 5% to 10 % in immunocompetent hosts [2,7]. 
Factors influencing the efficacy of antimicrobials in 
decreasing the relapse rate include bactericidal 
effectiveness, the ability to permeate the intracellular 
environment, as well as the appropriate dose and 
duration of therapy [8]. Fluoroquinolones and broad-
spectrum cephalosporins have a better treatment 
profile in this regard [9].    
To our surprise, when examining the entire 
cohort, we did not find any clinical or laboratory 
variables predictive of future relapse.  This may be 
due to the emergence of MDR strains of enteric fever 
during the study period leading to two clinically  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
distinct populations of patients within the cohort.  
When receiving partial courses or full therapy with 
fluoroquinolones the difference in relapse rates 
between MDR and pan-sensitive typhoid strains were 
not statistically significant.  As may be expected, 
however, patients with drug resistant typhoid who 
received ineffective therapy had a relapse rate almost 
twice that of those infected with pan-sensitive strains 
(Table 2).  
We found diarrhoea to be associated with lower 
relapse rates in children infected with pan-sensitive 
enteric fever whereas those infected with MDR 
strains had a higher relapse rate when presenting with 
constipation or starting specific therapy within 14 
days of fever onset. Perhaps of greater clinical 
significance, the use of quinolones or cephalosporins 
as part of the treatment course protected against 
subsequent relapse.  In those areas where MDR 
typhoid caused by S. Typhi is prevalent, it would be 
prudent to consider empirical treatment of patients 
with a cephalosporin or quinolone until infection is  
 
 
 
 Total n = 1650 
Clinical characteristic n (% of cases) 
Clinical toxicity 428 (32.0) 
Diarrhoea 612 (37.1) 
Constipation 143 (8.7) 
Abdominal Pain 658 (39.9) 
Abdominal Tenderness 385 (23.3) 
Hepatomegaly 657 (39.8) 
Splenomegaly 305 (18.5) 
Pallor 344 (20.8) 
Jaundice 31 (1.9) 
Cough 224 (13.6) 
Obtundation 91 (5.5) 
Hospital Admission 981 (59.5) 
Infection with MDR strain(s) 543 (32.9) 
Infection with S. Typhi strain(s) 1459 (88.4) 
Subsequent relapse 108 (6.5) 
  mean (SD) 
Age (years) 6.2 (3.9) 
Weight (kg) 18.3 (10.0) 
Days of illness at presentation 9.6 (9.8) 
Hemoglobin (mg/dL) 10.9 (1.7) 
White Blood Cell Count (103/µL) 9316 (5256) 
Table 1. Clinical characteristics of the cohort 
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proven to be caused by a drug sensitive strain.  This 
is now the standard treatment strategy in our 
institution and in our experience in much of South 
Asia. 
Although the reasons for our findings are unclear, 
one unifying possibility is that the clinical factors 
noted above may modify the load of Salmonella 
within the body and reticuloendothelial system 
(RES).  Treatment of MDR enteric fever with 
quinolones may be predicted to better eradicate 
Salmonella from the RES than treatment with first-
line antimicrobials.  Infection for greater than 14 days 
prior to therapy may lead to a greater immune system 
activation thereby allowing improved Salmonella 
clearance from the RES.  Likewise, as this organism 
is shed through the stool, it is possible that 
constipation may lead to a higher load of organism 
within the body whereas diarrhoea could be predicted 
to cause the opposite effect.  
Interpretation of our data may be limited as we 
report a single institutional experience rather than 
surveillance of a large population.  However, the age 
distribution in our study is similar to that of 
population based studies in India and 49% of patients 
were treated entirely as outpatients.  Although we 
defined relapse clinically and by identical 
antibiogram, more sophisticated techniques, 
including pulsed field gel electrophoresis (PFGE), 
have since become available to determine strain 
differences.  We would expect however that use of 
PFGE to detect relapse rather than antibiogram would 
lead to a clearer classification of patients with new 
infections compared to relapsed cases.  If this 
reinfection occurred in significant numbers however 
we expect use of the antibiogram would mask 
differences between the groups rather than lead to an 
increase in differences.     No MIC data is available 
from this time period; thus more subtle differences in 
MIC among “drug-sensitive” strains are not 
presented.   It is of note that the study period was 
prior to the emergence of widespread quinolone 
resistance in many parts of the world [10]. 
 
The strength of this study is that we report the 
largest known cohort of patients to examine the risk 
factors for enteric fever relapse in children.  This 
large cohort size allows for the robust subgroup 
analysis from which we report significant findings.  
Our institution has followed a standardized clinical 
treatment algorithm over many years which has 
allowed consistency in treatment regimens.  
Additionally, the study period encompasses the era 
during which MDR enteric fever emerged in South 
Asia, allowing direct comparison of drug-sensitive 
and MDR strains. 
In conclusion, we report clinical variables in 
patients infected with both drug-sensitive and MDR 
enteric fever that correlate with relapse after a clinical 
cure has been achieved.  These risk factors will be of 
value in creating treatment and follow-up algorithms 
for this large patient population. 
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Initial therapy of exclusively 
ampicillin, chloramphenicol, 
or TMP-SMX 
Partial or full Initial therapy 
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